Literature DB >> 2188847

Insulin-induced increase in heart rate and its prevention by propranolol.

A Siani1, P Strazzullo, N Giorgione, A De Leo, M Mancini.   

Abstract

Acute hyperinsulinaemia in the absence of changes in blood glucose increases heart rate in man. Animal studies have suggested that beta-adrenergic blockade does not prevent the insulin-induced increase in heart rate. The aim of the present study was to investigate the acute effect of insulin on heart rate and blood pressure in non diabetic subjects and, in particular, to determine whether beta-adrenergic receptor blockade would significantly influence the effect. On separate days 9 healthy young volunteers were pretreated with either 80 mg propranolol or placebo p.o. After a 60-90 min period of heart rate and blood pressure stabilization, a placebo injection was given intravenously and heart rate and blood pressure were then monitored every 5 min. After 30 min insulin Actrapid MC 0.2 IU/kg body weight was given i.v. A 20% glucose infusion was given to maintain blood glucose at its fasting level. After insulin administration, a rapid and statistically significant increase in heart rate was observed when the patients were pretreated with placebo; pretreatment with propranolol completely prevented this effect. Serum insulin levels were significantly higher than baseline at all times and there was no significant change in blood glucose. The results are consistent with the hypothesis that the insulin-induced increase in heart rate in man may result from stimulation of cardiac sympathetic activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2188847     DOI: 10.1007/bf00315583

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  10 in total

1.  Intravenous insulin causing loss of intravascular water and albumin and increased adrenergic nervous activity in diabetics.

Authors:  H J Gundersen; N J Christensen
Journal:  Diabetes       Date:  1977-06       Impact factor: 9.461

2.  Effects of hyperinsulinaemia on the cardiovascular responses to graded hypovolaemia in normal and diabetic subjects.

Authors:  A R Scott; T Bennett; I A MacDonald
Journal:  Clin Sci (Lond)       Date:  1988-07       Impact factor: 6.124

3.  Intravenous insulin has no effect on myocardial contractility or heart rate in healthy subjects.

Authors:  J Airaksinen; J T Lahtela; M J Ikäheimo; E A Sotaniemi; J T Takkunen
Journal:  Diabetologia       Date:  1985-09       Impact factor: 10.122

Review 4.  Acute effects of insulin on cardiovascular function and noradrenaline uptake and release.

Authors:  N J Christensen
Journal:  Diabetologia       Date:  1983-11       Impact factor: 10.122

5.  Stimulation of heart rate by insulin: uninfluenced by beta-adrenergic receptor blockade in rabbits.

Authors:  F Jacobsen; N J Christensen
Journal:  Scand J Clin Lab Invest       Date:  1979-05       Impact factor: 1.713

6.  Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man.

Authors:  J W Rowe; J B Young; K L Minaker; A L Stevens; J Pallotta; L Landsberg
Journal:  Diabetes       Date:  1981-03       Impact factor: 9.461

7.  Studies on the insulin-antagonistic effect of catecholamines in normal man. Evidence for the importance of beta 2-receptors.

Authors:  I Lager; S Attvall; B M Eriksson; H von Schenk; U Smith
Journal:  Diabetologia       Date:  1986-07       Impact factor: 10.122

8.  Cardiovascular effects of insulin: plasma volume changes in diabetics.

Authors:  J D Mackay; H Hayakawa; P J Watkins
Journal:  Diabetologia       Date:  1978-12       Impact factor: 10.122

9.  Cardiovascular effects of insulin.

Authors:  M M Page; R B Smith; P J Watkins
Journal:  Br Med J       Date:  1976-02-21

10.  The acute effect of insulin on heart rate, blood pressure, plasma noradrenaline and urinary albumin excretion. The role of changes in blood glucose.

Authors:  C E Mogensen; N J Christensen; H J Gundersen
Journal:  Diabetologia       Date:  1980-06       Impact factor: 10.122

  10 in total
  8 in total

1.  Leptin differentially increases sympathetic nerve activity and its baroreflex regulation in female rats: role of oestrogen.

Authors:  Zhigang Shi; Virginia L Brooks
Journal:  J Physiol       Date:  2014-12-22       Impact factor: 5.182

2.  Pre-Exercise Maltodextrin Ingestion and Transient Hypoglycemia in Cycling and Running.

Authors:  Costas Chryssanthopoulos; Evangelia Tzeravini; Elias Zachrogiannis; Maria Megalou; Alexander Kokkinos; Maria Maridaki; George Dimitriadis; Michaella Alexandrou; Chrysoula Kontrafouri; Damianos Papafilippou; Argyro Pountoukidou; Effraimia Tsolaki; Maria Evangelia Koloutsou; Nikolaos Zacharodimos; Michael Koutsilieris; Anastassios Philippou
Journal:  Int J Exerc Sci       Date:  2020-12-01

3.  Resistance to the sympathoexcitatory effects of insulin and leptin in late pregnant rats.

Authors:  Zhigang Shi; Kim M Hansen; Kristin M Bullock; Yoichi Morofuji; William A Banks; Virginia L Brooks
Journal:  J Physiol       Date:  2019-07-11       Impact factor: 5.182

4.  Autonomic responses to carbohydrate ingestion and head-up tilt in elderly subjects with orthostatic hypotension.

Authors:  B J Robinson; L I Stowell; G L Purdie; K T Palmer; R H Johnson
Journal:  Clin Auton Res       Date:  1992-10       Impact factor: 4.435

5.  Acute effects of euglycemic-hyperinsulinemia on myocardial contractility in male mice.

Authors:  Satya Murthy Tadinada; Wojciech J Grzesik; William Kutschke; Robert M Weiss; E Dale Abel
Journal:  Physiol Rep       Date:  2022-09

6.  Sites and sources of sympathoexcitation in obese male rats: role of brain insulin.

Authors:  Zhigang Shi; Ding Zhao; Priscila A Cassaglia; Virginia L Brooks
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-01-22       Impact factor: 3.619

7.  Effect of the long-acting insulin analogues glargine and degludec on cardiomyocyte cell signalling and function.

Authors:  Thorsten Hartmann; Sabrina Overhagen; D Margriet Ouwens; Silja Raschke; Paulus Wohlfart; Norbert Tennagels; Nina Wronkowitz; Jürgen Eckel
Journal:  Cardiovasc Diabetol       Date:  2016-07-15       Impact factor: 9.951

8.  Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice.

Authors:  Νarjes Nasiri-Ansari; Georgios K Dimitriadis; Georgios Agrogiannis; Despoina Perrea; Ioannis D Kostakis; Gregory Kaltsas; Athanasios G Papavassiliou; Harpal S Randeva; Eva Kassi
Journal:  Cardiovasc Diabetol       Date:  2018-07-26       Impact factor: 9.951

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.